Clinical Trials
4 trialsNCT00804856 2023-10-03
Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia
Boehringer Ingelheim
Phase 2 Completed
NCT01023958 2017-11-22
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
Boehringer Ingelheim
Phase 2 Completed
NCT00824408 2016-09-20
Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC
Boehringer Ingelheim
Phase 2 Completed
NCT01121406 2015-08-13
BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer
Boehringer Ingelheim
Phase 2 Completed